Got COVID-19? Vanderbilt needs you for medication research
NASHVILLE, Tenn. (Mike Osborne) — If you currently have COVID-19 you might consider signing up for a new Vanderbilt Medical Center research study.
The Activ-2 study is a nationwide effort to find medications that can help patients recover from the virus faster, or prevent serious illness that requires a hospital stay.
Adults 18 years and older who have tested positive for COVID-19 in the past seven days, are not in the hospital, and are symptomatic are encouraged to register.
Researchers are searching for COVID-19 treatments that are safe and reduce the amount of virus in the body, especially the lungs.
Among the treatments under study are monoclonal antibodies. Antibodies are produced by the body and attack viruses in an effort to keep them from damaging cells.
Test treatments may involve taking pills, receiving and injection, or an infusion.
Visit this website for additional details and study registration.